OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 45 filers reported holding OBALON THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 2,453,338 | $24,313,000 | 5.76% |
| Tamarack Advisers, LP | 528,066 | $5,233,000 | 3.06% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 330,427 | $3,274,000 | 0.50% |
| FORMULA GROWTH LTD | 108,998 | $1,080,000 | 0.19% |
| Moisand Fitzgerald Tamayo, LLC | 6,842 | $268,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,086 | $1,814,000 | 0.10% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 422,410 | $4,186,000 | 0.07% |
| TIVERTON ASSET MANAGEMENT LLC | 130,050 | $1,289,000 | 0.07% |
| Bellevue Group AG | 45,000 | $446,000 | 0.05% |
| Laird Norton Wetherby Wealth Management, LLC | 24,038 | $238,000 | 0.04% |